![](/img/cover-not-exists.png)
LOW-DOSE ORAL CHEMOTHERAPY FOR HORMONE-REFRACTORY PROSTATE CARCINOMA (HRPC). ESTRAMUSTINE PHOSPHATE VERSUS ESTRAMUSTINE PHOSPHATE AND ETOPOSIDE. A RANDOMISED PHASE II STUDY OF GSTU FOUNDATION
V. Serretta, G. Morgia, V. Altieri, A. Siragusa, M. Motta, F. Orestano, M. Napoli, G. De Grande, A. Galuffo, D. Melloni, C. Pavone, M. Pavone Macaluso, R. AllegroVolume:
5
Year:
2006
Language:
english
DOI:
10.1016/s1569-9056(06)60299-6
File:
PDF, 63 KB
english, 2006